Aboriginals with multiple sclerosis HLA types and predominance of neuromyelitis optica

Neurology

Volumn 56, Issue 3, 2001, Pages 317-323

  Mirsattari, S M ^a   Johnston, J B ^c   McKenna, R ^b   Del Bigio, M R ^a   Orr, P ^a   Ross, R T ^a   Power, Christopher ^a,b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c Department of Clinical Neuroscience ^*

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN; HLA DQ ANTIGEN; HLA DR ANTIGEN;

ABORIGINE; ADULT; ARTICLE; CANADA; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; ETHNIC DIFFERENCE; FEMALE; HLA TYPING; HUMAN; HUMAN HERPESVIRUS 6; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 1; MALE; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; OPTIC NERVE DISEASE; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RETROVIRUS; SPINAL CORD DISEASE; VIRUS INFECTION;

EID: 0035852870     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.56.3.317     Document Type: Article

References (51)

1. Pathogenesis of multiple sclerosis
2. A population-based study of multiple sclerosis in twins
3. Multiple sclerosis is associated with genes within or close to the HLA- DR-DQ subregion on a normal DR15,DQ6,Dw2 haplotype
4. Major histocompatibility complex class II alleles and the course and outcome of MS: A population-based study
5. Western versus Asian types of multiple sclerosis: Immunogenetically and clinically distinct disorders
6. The significance of oligoclonal bands in multiple sclerosis in Japan: Relevance of immunogenetic backgrounds
7. Molecular analysis of HLA class I (HLA-A and -B) and HLA class II (HLA- DRB1) genes in Japanese patients with multiple sclerosis (Western type and Asian type)
8. Possible viral cause of multiple sclerosis
9. Association of human herpes virus 6 (HHV-6) with multiple sclerosis: Increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA
10. Molecular identification of a novel retrovirus repeatedly isolated from patients with multiple sclerosis
11. Chlamydia pneumoniae infection of the central nervous system in multiple sclerosis
12. A 21 point unifying hypothesis on the etiology and treatment of multiple sclerosis
13. Epidemiology of multiple sclerosis in U.S. veterans: 1. Race, sex, and geographic distribution
14. Multiple sclerosis in Canadian native people
15. Epidemiology of multiple sclerosis: A critical overview
16. Prevalence of multiple sclerosis in Saskatoon
17. Demyelination and ethnicity: Experience at the University of British Columbia Multiple Sclerosis Clinic with special reference to HTLV-I-associated myelopathy in British Columbian natives
18. Multiple sclerosis in Winnipeg, Manitoba: Methodological considerations of epidemiologic survey, ten year follow-up of a community wide study, and population resurvey
19. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols
20. Infrequent detection of human herpesvirus 6 DNA in peripheral blood mononuclear cells from multiple sclerosis patients
21. Dysregulation of adenosine A1 receptor-mediated cytokine expression in peripheral blood mononuclear cells from multiple sclerosis patients
22. The Mayo Clinic-Canadian Cooperative trial of sulfasalazine in active multiple sclerosis
23. The varicella zoster virus: A pilot trial of a potential therapeutic agent in multiple sclerosis
24. On the ophthalmoscopic signs of spinal disease
25. Neuromyelitis optica (Devic's disease, Devic's syndrome)
26. Juvenile rheumatoid arthritis in a Canadian First Nations (aboriginal) population: Onset subtypes and HLA associations
27. Parental ancestry and risk of multiple sclerosis in Alberta, Canada
28. Clinical features
29. Multiple sclerosis in North-West India
30. Multiple sclerosis: Indian experience in the last thirty years
31. Multiple sclerosis-Indian experience
32. Clinical, CSF, and MRI findings in Devic's neuromyelitis optica
33. The clinical course of neuromyelitis optica (Devic's syndrome)
34. The natural history of multiple sclerosis: A geographically based study. I. Clinical course and disability
35. Devic's neuromyelitis optica: A clinicopathological study of 8 patients
36. HLA-DPB1*0501-associated opticospinal multiple sclerosis: Clinical, neuroimaging and immunogenetic studies
37. Leukoencephalopathy among native Indian infants in northern Quebec and Manitoba
38. Neuromyelitis optlca (Devic's syndrome) and pulmonary tuberculosis
39. M. tuberculosis molecular variation in CNS infection: Evidence for strain-dependent neurovirulence
40. HLA associations of seropositive rheumatoid arthritis in a Cree and Ojibway population
41. Recurrent optic neuromyelitis with endocrinopathies: A new syndrome
42. Devic's neuromyelitis optica: A clinicopathological review of the literature in connection with a case showing fatal dysautonomia
43. MRI and magnetization transfer imaging changes in the brain and cervical cord of patients with Devic's neuromyelitis optica
44. Eosinophilia triggered by beta-interferon therapy for chronic hepatitis C
45. Early eosinophilinfiltration into the optic nerve of mice with experimental allergic encephalomyelitis
46. Reverse transcriptase activity and particle production in B lymphoblastoid cell lines established from lymphocytes of patients with multiple sclerosis
47. Particle-associated retroviral RNA and tandem RGH/HERV-W copies on chromosome 7q: Possible components of a 'chain-reaction' triggered by infectious agents in multiple sclerosis
48. Retroviridae. The viruses and their replication
49. Molecular characterization and placental expression of HERV-W, a new human endogenous retrovirus family